Skip to search formSkip to main contentSkip to account menu

sulbutiamine

Known as: 2-isobutyrylthiamine disulfide, Propanoic acid, 2-methyl-, dithiobis(3-(1-(((4-amino-2-methyl-5-pyrimidinyl)methyl)formylamino)ethylidene)-3,1-propanediyl) ester, sulbutiamin 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

ArcalionEnerion

Broader (1)

Thiamine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Sulbutiamine Counteracts Trophic Factor Deprivation Induced Apoptotic Cell Death in Transformed Retinal Ganglion Cells
Sulbutiamine is a highly lipid soluble synthetic analogue of vitamin B1 and is used clinically for the treatment of asthenia. The… 
2007
2007
[Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease].
The efficacy of the inhibitors of acetylcholinesterase in Alzheimer's Disease (AD) is moderated and some patients do not respond… 
Review
2006
Review
2006
Sulbutiamine, an ‘innocent’ over the counter drug, interferes with therapeutic outcome of bipolar disorder
A case of a patient with bipolar disorder with a history of hospitalizations and addiction to sulbutiamine is presented… 
2005
2005
Chronic treatment with sulbutiamine improves memory in an object recognition task and reduces some amnesic effects of dizocilpine in a spatial delayed-non-match-to-sample task
2003
2003
Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia.
AIMS OF THE STUDY Asthenic symptoms such as weakness accompany illness. This study investigates whether the centrally acting… 
2000
2000
[Effects of sulbutiamine (Arcalion 200) on psycho-behavioral inhibition in major depressive episodes].
UNLABELLED Psycho-behavioural inhibition is characteristic of major depressive disorder and frequently recedes after the other… 
Review
1999
Review
1999
Pharmacologic and therapeutic features of sulbutiamine.
Asthenia is the most frequent medical reason for people seeking help from their physician. In 75% of cases, the cause is… 
1999
1999
[Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400-600 mg/day) versus placebo].
PURPOSE Chronic fatigue remains a medical mystery and a therapeutic failure. The subgroup of chronic fatigue postinfectious… 
Review
1999
Review
1999
Pharmacologic and therapeutic features of sulbutiamine.
Asthenia is the most frequent medical reason for people seeking help from their physician. In 75% of cases, the cause is… 
1985
1985
Chronic administration of sulbutiamine improves long term memory formation in mice: Possible cholinergic mediation
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)